Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Propafenone.

Literature DB >> 2405273

Propafenone.

C Funck-Brentano¹, H K Kroemer, J T Lee, D M Roden.

Abstract

Entities: Chemical

Mesh：

Substances：
Propafenone

Year: 1990 PMID： 2405273 DOI： 10.1056/NEJM199002223220806

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

26 in total

1. LG 6-101 and LG 6-102, two new propafenone-related antiarrhythmic agents with good oral activity in rats.

Authors: T C Wascher; P Dittrich; W R Kukovetz
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1992-04 Impact factor: 3.000

2. Transfer of propafenone and 5-OH-propafenone to foetal plasma and maternal milk.

Authors: M Libardoni; D Piovan; E Busato; R Padrini
Journal: Br J Clin Pharmacol Date: 1991-10 Impact factor: 4.335

Review 3. Drug effects on the electrocardiogram. A review of their clinical importance.

Authors: J D Symanski; L S Gettes
Journal: Drugs Date: 1993-08 Impact factor: 9.546

4. Propafenone hepatotoxicity: report of two new cases.

Authors: Daniel Cocozzella; José Curciarello; Osvaldo Corallini; Adriana Olivera; María Malca Alburquerque; Emilio Fraquelli; Liliana Zamagna; Alejandro Olenchuck; Alberto Cremona
Journal: Dig Dis Sci Date: 2003-02 Impact factor: 3.199

5. Rapid determination of CYP2D6 phenotype during propafenone therapy by analysing urinary excretion of propafenone glucuronides.

Authors: S Botsch; G Heinkele; C O Meese; M Eichelbaum; H K Kroemer
Journal: Eur J Clin Pharmacol Date: 1994 Impact factor: 2.953

Propafenone.

1. LG 6-101 and LG 6-102, two new propafenone-related antiarrhythmic agents with good oral activity in rats.

2. Transfer of propafenone and 5-OH-propafenone to foetal plasma and maternal milk.

Review 3. Drug effects on the electrocardiogram. A review of their clinical importance.

4. Propafenone hepatotoxicity: report of two new cases.

5. Rapid determination of CYP2D6 phenotype during propafenone therapy by analysing urinary excretion of propafenone glucuronides.

6. Identification of propafenone metaboliser phenotype from plasma and urine excretion data.

Review 7. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

8. Extemporaneous suspension of propafenone: attending lack of pediatric formulations in Mexico.

9. Effects of propafenone on 45Ca movements and contractile responses in vascular smooth muscle.

10. Stereoselective steady state disposition and action of propafenone in Chinese subjects.